Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erin R Burnight

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
The CRISPR Journal|April 26, 2019
CRISPR-Cas9-Mediated Correction of the 1.02 kb Common Deletion in <i>CLN3</i> in Induced Pluripotent Stem Cells from Patients with Batten DiseaseErin R Burnight, Laura R Bohrer, Joseph C Giacalone, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 2013
piggyBac transposase tools for genome engineeringXianghong Li, Erin R Burnight, Ashley L Cooney, et al.
Progress in Retinal and Eye Research|March 27, 2018
CRISPR-Cas9 genome engineering: Treating inherited retinal degenerationErin R Burnight, Joseph C Giacalone, Jessica A Cooke, et al.
Human Gene Therapy|November 22, 2017
Assessment of Adeno-Associated Virus Serotype Tropism in Human Retinal ExplantsLuke A Wiley, Erin R Burnight, Emily E Kaalberg, et al.
Human Gene Therapy|September 19, 2020
Retinal Tropism and Transduction of Adeno-Associated Virus Varies by Serotype and Route of Delivery (Intravitreal, Subretinal, or Suprachoroidal) in RatsIan C Han, Justine L Cheng, Erin R Burnight, et al.
Gene Therapy|September 14, 2021
Development and biological characterization of a clinical gene transfer vector for the treatment of MAK-associated retinitis pigmentosaBudd A Tucker, Erin R Burnight, Cathryn M Cranston, et al.
The CRISPR Journal|December 18, 2023
CRISPRi-Mediated Treatment of Dominant Rhodopsin-Associated Retinitis PigmentosaErin R Burnight, Luke A Wiley, Nathaniel K Mullin, et al.
Stem Cells Translational Medicine|May 23, 2023
Propensity of Patient-Derived iPSCs for Retinal Differentiation: Implications for Autologous Cell ReplacementJessica A Cooke, Andrew P Voigt, Michael A Collingwood, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 17, 2017
Using CRISPR-Cas9 to Generate Gene-Corrected Autologous iPSCs for the Treatment of Inherited Retinal DegenerationErin R Burnight, Manav Gupta, Luke A Wiley, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
The CRISPR Journal|April 26, 2019
CRISPR-Cas9-Mediated Correction of the 1.02 kb Common Deletion in <i>CLN3</i> in Induced Pluripotent Stem Cells from Patients with Batten DiseaseErin R Burnight, Laura R Bohrer, Joseph C Giacalone, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 2013
piggyBac transposase tools for genome engineeringXianghong Li, Erin R Burnight, Ashley L Cooney, et al.
Progress in Retinal and Eye Research|March 27, 2018
CRISPR-Cas9 genome engineering: Treating inherited retinal degenerationErin R Burnight, Joseph C Giacalone, Jessica A Cooke, et al.
Human Gene Therapy|November 22, 2017
Assessment of Adeno-Associated Virus Serotype Tropism in Human Retinal ExplantsLuke A Wiley, Erin R Burnight, Emily E Kaalberg, et al.
Human Gene Therapy|September 19, 2020
Retinal Tropism and Transduction of Adeno-Associated Virus Varies by Serotype and Route of Delivery (Intravitreal, Subretinal, or Suprachoroidal) in RatsIan C Han, Justine L Cheng, Erin R Burnight, et al.
Gene Therapy|September 14, 2021
Development and biological characterization of a clinical gene transfer vector for the treatment of MAK-associated retinitis pigmentosaBudd A Tucker, Erin R Burnight, Cathryn M Cranston, et al.
The CRISPR Journal|December 18, 2023
CRISPRi-Mediated Treatment of Dominant Rhodopsin-Associated Retinitis PigmentosaErin R Burnight, Luke A Wiley, Nathaniel K Mullin, et al.
Stem Cells Translational Medicine|May 23, 2023
Propensity of Patient-Derived iPSCs for Retinal Differentiation: Implications for Autologous Cell ReplacementJessica A Cooke, Andrew P Voigt, Michael A Collingwood, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 17, 2017
Using CRISPR-Cas9 to Generate Gene-Corrected Autologous iPSCs for the Treatment of Inherited Retinal DegenerationErin R Burnight, Manav Gupta, Luke A Wiley, et al.
Pageof 3